Brenntag (FRA:BNR) has been given a €56.00 ($69.14) price target by analysts at Goldman Sachs Group in a research report issued on Wednesday. The firm presently has a “neutral” rating on the stock. Goldman Sachs Group’s target price would suggest a potential upside of 11.73% from the stock’s current price.
Several other brokerages have also issued reports on BNR. Deutsche Bank set a €57.50 ($70.99) price target on Brenntag and gave the stock a “buy” rating in a report on Tuesday, December 19th. Warburg Research set a €63.00 ($77.78) price target on Brenntag and gave the stock a “buy” rating in a report on Wednesday, December 20th. JPMorgan Chase & Co. set a €56.47 ($69.72) price objective on Brenntag and gave the stock a “buy” rating in a research note on Monday, December 18th. HSBC set a €60.00 ($74.07) price objective on Brenntag and gave the stock a “buy” rating in a research note on Wednesday, January 10th. Finally, UBS Group set a €53.00 ($65.43) price objective on Brenntag and gave the stock a “neutral” rating in a research note on Monday, January 8th. One analyst has rated the stock with a sell rating, seven have given a hold rating and eleven have assigned a buy rating to the stock. Brenntag presently has an average rating of “Buy” and an average price target of €57.55 ($71.05).
Brenntag (BNR) opened at €50.12 ($61.88) on Wednesday. The stock has a market capitalization of $8,080.00 and a P/E ratio of 19.35. Brenntag has a fifty-two week low of €43.06 ($53.16) and a fifty-two week high of €56.25 ($69.44).
Brenntag AG, a chemical distribution company, provides distribution solutions for industrial and specialty chemicals worldwide. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.